Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy
NCT07424677
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
89
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Biliary Cholangitis
Interventions
DRUG:
Saroglitazar Magnesium 1 mg
DRUG:
Placebo
Sponsor
Zydus Therapeutics Inc.